Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +1.52% advanced 1.52% to $121.94 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.02% rising 0.92% to 4,713.07 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.34% rising 0.51% to 36,252.02. The stock's rise snapped a seven-day losing streak. Edwards Lifesciences Corp. closed $9.79 short of its 52-week high ($131.73), which the company reached on December 30th.
The stock underperformed when compared to some of its competitors Tuesday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT +2.36% rose 2.15% to $107.89, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +3.77% rose 2.33% to $43.40, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI +2.79% rose 3.20% to $235.41. Trading volume (2.4 M) eclipsed its 50-day average volume of 2.4 M.